Please wait

cialis drug - Home Page

using lower concentrations of target or increasing the concentration of nonspecific competitors during the partitioning step), it is possible to drive enrichment of those sequence variants with the strongest affinity. Sequencing individual clones within the reselected library typically reveals a handful of preferred sequence changes that can often be combined in composite variants to yield the highest-affinity sequences. Through this process, fiveto tenfold improvements in KDare often observed. An alternative means for improving affinity involves the introduction of site-specific chemical modifications that cannot be accessed through simple changes in nucleotide sequence. 2 modifications (e.g., 2 -deoxy ? 2 -O-methyl, 2 -hydroxy ? 2 -O-methyl), phosphate modifications (e.g., phosphodiester ? phosphorothioate), and nucleobase modifications (e.g., uridine ? thymidine, guanosine ? inosine) have all been shown to have beneficial effects on cialis affinity when introduced in the appropriate context . Some of these modifications likely function by improving the folding of the aptamer, favoring either a more rigid structure or preventing its misfolding into inactive conformations. Other modifications likely function to optimize the overall steric fit between the cialis drug and the target or introduce additional stabilizing pairwise interactions to drive binding. Sites where modifications are beneficial (or even tolerated) cannot generally be predicted, even when the secondary structure of the cialis drug is clearly defined. As such, a typical optimization approach involves systematically synthesizing and testing a series of single-site variants in which a given type of substitution is individually introduced at each successive position within an aptamer. The effect of substitutions is assessed by comparing the variant target-binding affinity to the parental affinity—all modifications that individually improve target binding may be simultaneously combined to create a single composite molecule. Effects are quite often additive with multiple incremental improvements in binding combining to yield substantial net gains in affinity . In the course of a typical optimization process, approximately 100 different variants may be tested and affinity improved by 100- to 1000-fold (Figure 28.3). Depending upon the composition of the starting SELEX pool and the desired therapeutic application, it may be necessary to engineer increased nuclease resistance into an cialis drug to ultimately achieve a desired in vivo half-life. Both exonucleases and endonucleases play a role in defining the rate and pathway by which aptamers are degraded in serum. As described in the following sections, several different types of modifications can be introduced to limit the activity of these enzymes. 3 ? 5 -directed exonucleases are responsible for the much of the cleavage of unstabilized nucleic acids . Nucleotide or nonnucleotide caps attached to the 3 end of an tadalafil online can effectively block such exonucleases, making endonucleolytic cleavage the preferred pathway for degradation. For historical reasons, the inverted deoxythymidine (idT) cap has been used in many therapeutic aptamers although other approaches (e.g., PEGylation, biotinylation) appear to be equally effective. By simply conjugating a deoxythymidine nucleotide via a 3 -3 linkage to an otherwise unstabilized DNA aptamer, serum half-life is increased from minutes to approximately 1 h .